Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma
ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNantes University Hospital
About this trial
Glaucoma is a chronic disease of the optic nerve, characterized by progressive loss of nerve cells in the retina, leading to progressive loss of peripheral and central vision. There are in fact several types of glaucoma, which is the world's second leading cause of blindness after cataracts, and the leading cause of irreversible blindness.
To date, to our knowledge, there is no work analyzing the progression of angiographic OCT in patients with glaucoma.
The main aim of this study is to compare the 3-year progression rate of 3 examinations in advanced glaucoma patients: one functional (visual field) and two anatomical (OCTa and OCTrnfl).
Eligibility criteria
Qualifiers
Men and women aged 18 and over
Patient with glaucoma followed in the ophthalmology department of Nantes University Hospital
mean visual field deficit (MD) >10dB
Disqualifiers
Retinal vascular pathology (moderate to severe non-proliferative diabetic retinopathy, complicated diabetic retinopathy, OVCR/OBVR, OACR/OBAR, NOIAA...) Non-glaucomatous optic neuropathy, neurological pathology leading to visual field deficit (stroke with HLH, quadranopsia, chiasmatic Sd...)
PPR (retinal PanPhotocoagulation), retinal cerclage
Retinal pathology leading to visual field impairment (e.g. retinitis pigmentosa)
AMD and other macular pathologies that can lead to central visual field deficits
Trial design
Treatments tested in this trial
- OCT
Treatment groups
No treatment groups listed
Locations
2CHU Nantes44000, NantesNantes, France
Jean-Baptiste Ducloyer44093, NantesNantes, France
Sponsors and collaborators
Nantes University Hospital
Lead sponsor
Source ClinicalTrials.gov